| Notice | Country | Deadline | Value |
|---|
| Inhaled Nitric Oxide | United States | 2026-10-22 | — |
| Methylphenidate ER | United States | 2026-10-23 | — |
| Methylphenidate ER | United States | 2026-10-23 | — |
| Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Addi | United States | 2026-10-26 | — |
| 6505--Imatinib Tablets | United States | 2026-10-30 | — |
| Epinephrine Injector | United States | 2026-11-02 | — |
| LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION | United States | 2026-11-03 | — |
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 | United States | 2026-11-03 | — |
| Methylphenidate ER | United States | 2026-11-06 | — |
| Epinephrine Injector | United States | 2026-11-16 | — |
| 6505--Department of Veterans Affairs Pharmaceutical Industry Day | United States | 2026-11-20 | — |
| Morphine Sulfate Solution | United States | — | — |
| 19AQMM26F1521 - Sole Source Justification Under Federal Supply Schedule: 20262027 Flu vaccines | United States | — | — |
| Sanofi 20262027 Flu Vaccines | United States | — | — |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | United States | 2026-10-21 | — |
| 6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center | United States | 2026-10-15 | — |
| Febuxostat Tablets | United States | 2026-10-15 | — |
| Pravastatin Solicitation | United States | — | 15.3m USD |
| Notice of Intent to Sole Source – CARDINAL HEALTH 414, LLC– radiopharmaceuticals | United States | 2026-10-19 | — |
| 6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center | United States | 2026-10-15 | — |
| 6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center | United States | 2026-10-15 | — |
| Quetiapine Fumarate XR Tablets | United States | — | 4.3m USD |
| IHC Reagents and Supplies | United States | — | 349.7k USD |
| 6505--Imatinib Tablets | United States | 2026-10-16 | — |
| 6505--Latanoprost Ophthalmic Solution (VA-27-00006027) | United States | 2026-10-16 | — |
| 6505--Notice of Intent to Sole-Source for Pluvicto (Lutetium Lu 177 Vipivotide Tetraxetan) and | United States | 2026-10-15 | — |
| SNS Pharmaceutical Logistic Replenishment Requirement | United States | — | 80.5m USD |
| 6505--Radiopharmaceuticals | United States | — | 6.8m USD |
| 6505--Lab Supplies | Radiopharm | New 5 year consolidation Lebanon & Pittsburgh - Illuccix | 59 | United States | — | 4.6m USD |
| 6505--Fluorodeoxyglucose (FDG) Radiopharmaceutical | United States | — | 637.6k USD |
| 6505--JAPANESE ENCEPHALITIS VIRUS VACCINE IXIARO | United States | — | 787.4k USD |
| 6505--Rh-82 Rhubidium Generator - Iowa City VA | United States | — | 362.9k USD |
| 6505--PET MRI Radiopharmaceuticals, Detroit | United States | — | 557.7k USD |
| PLUVICTO - Northern California VA | United States | — | 3.1m USD |
| FDA-Approved Radiopharmaceutical Supplies and Cold Kits | United States | — | 2.4m USD |
| 6505--Chemo Compounding - East Orange | United States | — | 1.9m USD |
| PLUVICTO Palo Alto VA | United States | — | 4.1m USD |
| 6505--Rubidium (Rb-82) Generators, 612-C79072, Base: 10/01/26 - 09/30/27 Base plus 1 Option Ye | United States | — | 675.1k USD |
| 6505--VALL Iodine Isotope IDIQ | United States | — | 52.6k USD |
| 6505--Supplies - Radioactive Isotopes - Ann Arbor | United States | — | 5.2m USD |
| BULK PHARMACEUTICAL BUY FOR SNS WAREHOUSES (CHARTWELL RX, LLC) | United States | 2027-09-29 | 21.9m USD |
| PROCUREMENT OF PHARMACEUTICALS - DOXYCYCLINE, SODIUM CHLORIDE, AND METHYLPREDNISOLONE | United States | 2027-09-29 | 24.4m USD |
| BULK PHARMACEUTICAL REPLENISHMENT | United States | 2027-09-29 | 18.6m USD |
| 6505--Prednisolone 1% Ophthalmic Solution | United States | 2026-10-14 | — |
| 6505--Deciphera Pharmaceuticals LLC (65IB), 36F79726D0211, Effective 09/29/2026 - 09/28/2031 | United States | — | 183.8m USD |
| 6505--Prednisolone 1% Ophthalmic Solution | United States | 2026-10-15 | — |
| 6505--Wilshire Pharmaceuticals, 36F79726D0208, Schedule 65 I B Effective Dates: 09/29/2026 -0 | United States | — | 27.2m USD |
| WBAMC Microspheres | United States | 2026-09-30 | — |
| Olopatadine HCL 0.1% Ophthalmic Solution | Canada | — | 17.6m USD |
| 6505--60 Degrees Pharmaceuticals, Inc. 65IB 36F79726D0212 9/29/2026 TO 9/28/2031 | United States | — | 475.0k USD |
| 6505--Cytokinetics, Incorporated Effective: 09/29/2026 - 09/28/2031 | United States | — | 500.0k USD |
| Febuxostat Tablets | United States | 2026-10-15 | — |
| 6505--Genzyme Corporation | United States | — | 670.0m USD |